Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2008 (2008), Article ID 737141, 7 pages
Clinical Study

Serum Amyloid A, Procalcitonin, Tumor Necrosis Factor- , and Interleukin-1 Levels in Neonatal Late-Onset Sepsis

Department of Pediatrics, Faculty of Medicine, Eskisehir Osmangazi University, 26480 Eskisehir, Turkey

Received 25 March 2008; Revised 14 August 2008; Accepted 25 August 2008

Academic Editor: Ariadne Malamitsi-Puchner

Copyright © 2008 Birsen Ucar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. Sepsis is an important cause of mortality in newborns. However, a single reliable marker is not available for the diagnosis of neonatal late-onset sepsis (NLS). The aim of this study is to evaluate the value of serum amyloid A (SAA) and procalcitonin (PCT) in the diagnosis and follow-up of NLS. Methods. 36 septic and healthy newborns were included in the study. However, SAA, PCT, TNF- , IL-1 , and CRP were serially measured on days 0, 4, and 8 in the patients and once in the controls. Töllner's sepsis score (TSS) was calculated for each patient. Results. CRP, PCT, and TNF- levels in septic neonates at each study day were significantly higher than in the controls ( ). SAA and IL-1 levels did not differ from healthy neonates. The sensitivity and specificity were 86.8% and 97.2% for PCT, 83.3% and 80.6% for TNF- , 75% and 44.4% for SAA on day 0. Conclusion. Present study suggests that CRP seems to be the most helpful indicator and PCT and TNF- may be useful markers for the early diagnosis of NLS. However, SAA, IL-1 , and TSS are not reliable markers for the diagnosis and follow-up of NLS.